Who is sponsoring NCT05546112?

NCT05546112 is sponsored by Ybrain Inc..

Is NCT05546112 still recruiting?

NCT05546112 is currently status unknown. Last updated 22 September 2022.

Last reviewed 2022-09-22 · How we verify

NCT05546112

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Efficacy and Safety of At-home Transcutaneous Electrical Nerve Stimulation in Insomnia

Status unknown NA Last updated 22 September 2022

What this trial tests

NA trial testing Transcutaneous Trigeminal Electrical Nerve Stimulation using YPS-401B in Insomnia in 30 participants. Status unknown.

Timeline

4 October 2022

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Ybrain Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	30
Start date	4 October 2022
Primary completion	31 December 2022
Estimated completion	31 December 2022

Drugs / interventions tested

Transcutaneous Trigeminal Electrical Nerve Stimulation using YPS-401B
Sham Stimulation using YPS-401B

Conditions studied

Insomnia — all drugs for Insomnia →

Sponsor

Ybrain Inc. — full company profile →

Who can join

Adults 19 to 65, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the effects and safety of transcutaneous electrical nerve stimulation (TENS) at home for patients diagnosed with insomnia on the improvement of insomnia and nervous stability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting

Other Ybrain Inc. trials

Trials by the same sponsor.

NCT04720040 — The Efficacy and Safety of tDCS in Patients With Mild to Moderate Major Depressive Disorder · NA · completed
NCT05495113 — The Efficacy and Safety of tDCS in Patients With Mild Dementia · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05546112 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ybrain Inc.
Last refreshed: 22 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05546112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing